To assess this effect, three NSCLC cell types, including EGFR-TKI-sensitive PC-9, acquired-resistance PC-9 and primary-resistance H1975 cells, were investigated in vitro. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.